COLECCHIA, MAURIZIO
 Distribuzione geografica
Continente #
EU - Europa 744
NA - Nord America 554
AS - Asia 515
SA - Sud America 6
Totale 1.819
Nazione #
US - Stati Uniti d'America 550
SE - Svezia 327
CN - Cina 246
SG - Singapore 243
IT - Italia 175
RU - Federazione Russa 140
FI - Finlandia 46
DE - Germania 19
IN - India 7
JP - Giappone 7
NL - Olanda 7
RO - Romania 7
GB - Regno Unito 6
IE - Irlanda 6
CA - Canada 4
PL - Polonia 4
HK - Hong Kong 3
IQ - Iraq 3
CO - Colombia 2
ES - Italia 2
GR - Grecia 2
IR - Iran 2
PE - Perù 2
BE - Belgio 1
BR - Brasile 1
EC - Ecuador 1
KZ - Kazakistan 1
LT - Lituania 1
PK - Pakistan 1
TR - Turchia 1
UA - Ucraina 1
VN - Vietnam 1
Totale 1.819
Città #
Lawrence 150
Princeton 150
Singapore 144
Shanghai 128
Moscow 103
Milan 69
New York 63
Helsinki 37
Boardman 27
Ashburn 22
Guangzhou 14
Los Angeles 13
Shenzhen 11
Rozzano 10
Lappeenranta 9
Rome 9
Jiaxing 8
Naples 8
Cluj-Napoca 7
Dublin 6
Turin 5
Chyliczki 4
Kassel 4
Pune 4
Rockville 4
Christchurch 3
Dallas 3
Erbil 3
Hong Kong 3
Terracina 3
Washington 3
Atlanta 2
Barcelona 2
Beijing 2
Bogotá 2
Buccinasco 2
Buffalo 2
Cedar Knolls 2
Chiba 2
Foshan 2
Frankfurt am Main 2
Genoa 2
Kyoto 2
Lima region 2
London 2
Martina Franca 2
Mumbai 2
Naaldwijk 2
Nanjing 2
Sala Baganza 2
Santa Clara 2
Tokyo 2
Trezzano sul Naviglio 2
Wuhu 2
Wuxi 2
Yiwu 2
Amsterdam 1
Astana 1
Athens 1
Bellizzi 1
Bengbu 1
Bologna 1
Borås 1
Brussels 1
Cuenca 1
Dongyang 1
Gainesville 1
Haining 1
Hamamatsu 1
Hangzhou 1
Ho Chi Minh City 1
Jinhua 1
Kaunas 1
Kunming 1
Larissa 1
Macerata 1
Mountain View 1
Mykolayiv 1
Nuremberg 1
Padova 1
Pioltello 1
Poggiomarino 1
Qingdao 1
Quanzhou 1
Redwood City 1
Salvador 1
Seattle 1
Tianjin 1
Torino 1
Xi'an 1
Totale 1.111
Nome #
Liquid biopsy of cerebrospinal fluid enabling the detection and therapeutic targeting of the BRAFV600E mutation in a patient with overlapping Erdheim-Chester/Rosai-Dorfman disease 38
[18F]Fluoro-Deoxy-Glucose positron emission tomography to evaluate lymph node involvement in patients with muscle-invasive bladder cancer receiving neoadjuvant pembrolizumab 33
Impact of Molecular Subtyping and Immune Infiltration on Pathological Response and Outcome Following Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer 32
Sex cord stromal tumors and tumors of the paratestis: new and old entities in a landscape of rare tumors 29
A feasibility study of preoperative pembrolizumab before radical nephroureterectomy in patients with high-risk, upper tract urothelial carcinoma: PURE-02 29
Does the administration of preoperative pembrolizumab lead to sustained remission post-cystectomy? First survival outcomes from the PURE-01 study☆ 25
Cabozantinib Plus Durvalumab in Patients With Advanced Urothelial Carcinoma After Platinum Chemotherapy: Safety and Preliminary Activity of the Open-Label, Single-Arm, Phase 2 ARCADIA Trial 25
Leiomyoadenomatoid tumours of the epididymis: A new case report and review of the literature 24
Total embedding of spermatic cord and hilar soft tissue in orchiectomy for seminoma: does the extensive sampling improve pathologic risk factors? 23
Laparoscopic Postchemotherapy Retroperitoneal Lymph-Node Dissection Can Be a Standard Option in Defined Nonseminomatous Germ Cell Tumor Patients 23
Pathology of testicular and penile neoplasms 23
[The treatment of early-stage germ cell tumors of the testis (GCTT)]. [Il trattamento dei Tumori Germinali del Testicolo (TGT) in fase iniziale.] 22
A Combination of Cisplatin and 5-Fluorouracil With a Taxane in Patients Who Underwent Lymph Node Dissection for Nodal Metastases From Squamous Cell Carcinoma of the Penis: Treatment Outcome and Survival Analyses in Neoadjuvant and Adjuvant Settings 22
The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: Definition of Grading Patterns and Proposal for a New Grading System 21
Incidence and Clinical Impact of Inflammatory Fluorodeoxyglucose Positron Emission Tomography Uptake After Neoadjuvant Pembrolizumab in Patients with Organ-confined Bladder Cancer Undergoing Radical Cystectomy 20
Pancreatic metastases after surgery for renal cell carcinoma: survival and pathways of progression 19
Brentuximab Vedotin in CD30-Expressing Germ Cell Tumors After Chemotherapy Failure 19
Cabozantinib as First-line Treatment in Patients With Metastatic Collecting Duct Renal Cell Carcinoma: Results of the BONSAI Trial for the Italian Network for Research in Urologic-Oncology (Meet-URO 2 Study) 18
An Open-label Randomized Phase 2 study of Durvalumab Alone or in Combination with Tremelimumab in Patients with Advanced Germ Cell Tumors (APACHE): Results from the First Planned Interim Analysis 18
Clinical Outcome in Testicular Sex Cord Stromal Tumors: Testis Sparing vs Radical Orchiectomy and Management of Advanced Disease 18
A Case of Plasmacytoid Variant of Bladder Cancer With a Single Penile Metastasis and a Complete Response to Carboplatin-Based Chemotherapy and Review of the Literature. 18
A new mutation in the KIT ATP pocket causes acquired resistance to imatinib in a gastrointestinal stromal tumor patient 18
A case report of myoid gonadal stromal tumor treated with testis sparing surgery 17
Re: Updated Results of PURE-01 with Preliminary Activity of Neoadjuvant Pembrolizumab in Patients with Muscle-Invasive Bladder Carcinoma with Variant Histologies 17
Teratoma With Somatic-Type Malignant Components in Germ Cell Tumors of the Testis: A Clinicopathologic Analysis of 40 Cases With Outcome Correlation 17
CD 57 Antigen 17
Prostatic and urothelial metastasis in the same lymph node: a case report 17
Carney triad: case report and molecular analysis of gastric tumor 17
Anti-Müllerian hormone predicts positive sperm retrieval in men with idiopathic non-obstructive azoospermia-findings from a multi-centric cross-sectional study 16
Renal tumor biopsy in patients with cT1b-T4-M0 disease susceptible to radical nephrectomy: analysis of safety, accuracy and clinical impact on definitive management 16
An open-label, single-arm, phase 2 study of the Aurora kinase A inhibitor alisertib in patients with advanced urothelial cancer 16
Multicenter Validation of Histopathologic Tumor Regression Grade After Neoadjuvant Chemotherapy in Muscle-invasive Bladder Carcinoma 16
The Leydig cell tumour Scaled Score (LeSS): a method to distinguish benign from malignant cases, with additional correlation with MDM2 and CDK4 amplification 16
Atypical pleomorphic epithelioid angiomyolipoma localized to the pelvis: a case report and review of the literature 16
Assessment and reporting of pathological findings of penile specimens 16
Prediction of grade reclassification of prostate cancer patients on active surveillance through the combination of a three-mirna signature and selected clinical variables 16
Potential of the Stromal Matricellular Protein Periostin as a Biomarker to Improve Risk Assessment in Prostate Cancer 15
p15INK4b, p14ARF, and p16INK4a inactivation in sporadic and neurofibromatosis type 1-related malignant peripheral nerve sheath tumors 15
Benign glomus tumor of the urinary bladder. 15
Erratum to 'Core Biopsies from Prostate Cancer Patients in Active Surveillance Protocols Harbor PTEN and MYC Alterations'[European Urology Oncology 2 (2019) 277-285 14
Mediastinal germ cell tumors: A narrative review of their traits and aggressiveness features 14
Prostatic metastases from testicular nonseminomatous germ cell cancer: Two case reports and a review of the literature 14
Neoadjuvant sorafenib, gemcitabine, and cisplatin administration preceding cystectomy in patients with muscle-invasive urothelial bladder carcinoma: An open-label, single-arm, single-center, phase 2 study 14
Understanding the somatic-type malignant differentiation in male germ-cell cancer: A work in progress. Response to the article by Spiess et al., Malignant transformation of testicular teratoma: A chemoresistant phenotype. Urol Oncol 2008;26:595-9 14
First-line therapy with dacomitinib, an orally available pan-HER tyrosine kinase inhibitor, for locally advanced or metastatic penile squamous cell carcinoma: results of an open-label, single-arm, single-centre, phase 2 study 14
Association of Androgen Receptor Expression on Tumor Cells and PD-L1 Expression in Muscle-Invasive and Metastatic Urothelial Carcinoma: Insights for Clinical Research 14
TAMs PD-L1(+) in the reprogramming of germ cell tumors of the testis 13
Validation of a Novel Three-Dimensional (3D Fusion) Gross Sampling Protocol for Clear Cell Renal Cell Carcinoma to Overcome Intratumoral Heterogeneity: The Meet-Uro 18 Study 13
Neoplasie dell'Apparato genitale maschile: Testicolo 13
Neoplasie dell'apparato genitale maschile: Carcinoma del Pene 13
Prognostic Effect of FGFR Mutations or Gene Fusions in Patients with Metastatic Urothelial Carcinoma Receiving First-line Platinum-based Chemotherapy: Results from a Large, Single-institution Cohort 13
Penile cancer 13
Treatment and Clinical Outcomes of Patients with Teratoma with Somatic-Type Malignant Transformation: An International Collaboration 13
The Relationship between Characteristics of Inguinal Lymph Nodes and Pelvic Lymph Node Involvement in Penile Squamous Cell Carcinoma: A Single Institution Experience 13
Predicting the pathologic complete response after neoadjuvant pembrolizumab in muscle-invasive bladder cancer 13
Pembrolizumab and nab-paclitaxel as salvage therapy for platinum-treated, locally advanced or metastatic urothelial carcinoma: interim results of the open-label, single-arm, phase II PEANUT study 13
Detection Rate of Anterior Prostate Cancer in 226 Patients Submitted to Initial and Repeat Transperineal Biopsy 13
Immunophenotypic and genotypic analysis of a case of primary peripheral primitive neuroectodermal tumour (pPNET) of the urinary bladder 13
Carcinoma tiroideo iperfunzionante.Descrizione di un caso. 13
Frequent mutation and nuclear localization of β-catenin in sertoli cell tumors of the testis 13
The 2019 genitourinary pathology society (GUPS) white paper on contemporary grading of prostate cancer 13
How do endoscopic bladder tumor resection techniques affect pathology practice? EAU Section of Uro-Technology (ESUT) and Uropathology (ESUP) survey 12
Evaluation of an institutional series of low-grade oncocytic tumor (LOT) of the kidney and review of the mutational landscape of LOT 12
Fumarate hydratase-deficient testicular sex cord-stromal tumour (FH-TSCST): proposal for reclassification of a subset of Leydig cell tumours with distinct molecular and clinicopathologic features 12
Proof of Activity of Anti-Epidermal Growth Factor Receptor-Targeted Therapy for Relapsed Squamous Cell Carcinoma of the Penis 12
Panitumumab Treatment for Advanced Penile Squamous Cell Carcinoma When Surgery and Chemotherapy Have Failed 12
Treatment of Carcinoma In Situ of the Glans Penis With Topical Imiquimod Followed by Carbon Dioxide Laser Excision 12
The Value of Multiparametric Magnetic Resonance Imaging Sequences to Assist in the Decision Making of Muscle-invasive Bladder Cancer 12
Eleven-year management of prostate cancer patients on active surveillance: what have we learned? 12
Myomelanocytic tumor of the thigh 12
Lack of SYT-SSX fusion transcripts in malignant peripheral nerve sheath tumors on RT-PCR analysis of 34 archival cases 12
Clinicopathologic and molecular genetic characterization of low-grade fibromyxoid sarcoma, and cloning of a novel FUS/CREB3L1 fusion gene 12
pT1 penile squamous cell carcinoma: a clinicopathologic study of 56 cases treated by CO2 laser therapy 12
Quality of surgery and outcome in extra-abdominal aggressive fibromatosis: a series of patients surgically treated at a single institution 12
Reappraisal of Morphologic Differences Between Renal Medullary Carcinoma, Collecting Duct Carcinoma, and Fumarate Hydratase-deficient Renal Cell Carcinoma 12
Chordoma: natural history and results in 28 patients treated at a single institution 12
Practice patterns related to prostate cancer grading: results of a 2019 Genitourinary Pathology Society clinician survey 12
Integrative transcriptomic analysis reveals distinctive molecular traits and novel subtypes of collecting duct carcinoma 12
Implementation of preventive and predictive BRCA testing in patients with breast, ovarian, pancreatic, and prostate cancer: a position paper of Italian Scientific Societies 11
Neoadjuvant pembrolizumab and radical cystectomy in patients with muscle-invasive urothelial bladder cancer: 3-year median follow-up update of PURE-01 trial 11
Laparoscopic Retroperitoneal Lymph Node Dissection for Clinical Stage I Nonseminomatous Germ Cell Tumors of the Testis: Safety and Efficacy Analyses at a High Volume Center 11
Relationship between lymph node ratio and cancer-specific survival in a contemporary series of patients with penile cancer and lymph node metastases 11
Molecular Signature of Response to Pazopanib Salvage Therapy for Urothelial Carcinoma 11
Concordance and Prediction Ability of Original and Reviewed Vascular Invasion and Other Prognostic Parameters of Clinical Stage I Nonseminomatous Germ Cell Testicular Tumors After Retroperitoneal Lymph Node Dissection 11
EAU-EANM-ESTRO-ESUR-SIOG Prostate Cancer Guideline Panel Consensus Statements for Deferred Treatment with Curative Intent for Localised Prostate Cancer from an International Collaborative Study (DETECTIVE Study) 11
Persistent CD30 Expression by Embryonal Carcinoma in the Treatment Time Course: Prognostic Significance of a Worthwhile Target for Personalized Treatment 11
Pembrolizumab as neoadjuvant therapy before radical cystectomy in patients with muscle-invasive urothelial bladder carcinoma (PURE-01): An open-label, single-arm, phase II study 11
Tumors of the testis and paratesticular structures 11
Imatinib mesylate in chordoma 11
Different effects of calcitriol and parathyroidectomy on the PTH-calcium curve in dialysis patients with severe hyperparathyroidism 11
Teratoma with somatic-type malignant components of the testis. A review and an update 11
Pseudoglandular (adenoid, acantholytic) penile squamous cell carcinoma 11
Images in pathology. Morphologic features of response to Gleevec (Imatinib) treatment of GIST 11
Myoid gonadal tumor. Case series, systematic review, and Bayesian analysis 11
The contributions of Juan Rosai to testicular pathology with personal remembrances 11
Cystic Clear Cell Renal Cell Carcinoma: A Morphological and Molecular Reappraisal 11
Role of Follicle-stimulating Hormone, Inhibin B, and Anti-Müllerian Hormone in Predicting Sperm Retrieval from Men with Nonobstructive Azoospermia Undergoing Microdissection Testicular Sperm Extraction: A Systematic Review and Meta-analysis 10
Definition and Diagnosis of Oligometastatic Bladder Cancer: A Delphi Consensus Study Endorsed by the European Association of Urology, European Society for Radiotherapy and Oncology, and European Society of Medical Oncology Genitourinary Faculty 10
Exceptional response to olaparib in BRCA2-altered urothelial carcinoma after PD-L1 inhibitor and chemotherapy failure 10
Evaluation of AgNOR count in distinguishing benign from malignant mesothelial cells in pleural fluids 10
Totale 1.527
Categoria #
all - tutte 39.711
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.711


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203 0 0 0 0 0 0 0 0 1 2 0 0
2020/2021135 0 0 0 0 35 7 2 0 91 0 0 0
2021/2022101 0 5 2 30 6 2 28 6 3 1 5 13
2022/2023700 351 150 37 4 1 89 11 32 10 6 5 4
2023/2024494 13 27 30 154 21 74 44 35 7 22 15 52
2024/2025636 396 32 70 44 94 0 0 0 0 0 0 0
Totale 2.072